Shimatsu A, Biller B, Fleseriu M, Lee E jig, Leelawaflana R, Kim JH, et al. OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY). J ASEAN Fed Endocr Soc [Internet]. 2022 Oct. 14 [cited 2026 May 5];37(2):75-6. Available from: https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/6075